ResearcherOita UniversityActive in the last 2 years
Kazunari Murakami
Matched on ORCID iD 0000-0003-2668-5039; OpenAlex author ID A5032714468. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 0, last author 4)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 13
2018: 1 paper · 2019: none · 2020: none · 2021: 1 paper · 2022: 1 paper · 2023: 2 papers · 2024: 1 paper
Papers 6
- Endoscopic Ultrasound Can Differentiate High-Grade Pancreatic Intraepithelial Neoplasia, Small Pancreatic Ductal Adenocarcinoma, and Benign Stenosis. Last author DOI 10.5009/gnl220521↗
- Pancreatic cancer with pseudoaneurysm after duckbill-shaped anti-reflux metal stent placement: A case report. Last author DOI 10.1002/deo2.203↗
- Involvement of clusterin expression in the refractory response of pancreatic cancer cells to a MEK inhibitor. Co-author DOI 10.1111/cas.15735↗
- Diagnostic Strategy of Early Stage Pancreatic Cancer via Clinical Predictor Assessment: Clinical Indicators, Risk Factors and Imaging Findings. Last author DOI 10.3390/diagnostics12020377↗
- Downregulation of ZNF395 Drives Progression of Pancreatic Ductal Adenocarcinoma through Enhancement of Growth Potential. Co-author DOI 10.1159/000514593↗
- Utility of Endoscopic Ultrasonography Screening for Small Pancreatic Cancer and Proposal for a New Scoring System for Screening. Last author DOI 10.1097/mpa.0000000000000988↗
Closest collaborators
The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Ryota Sagami · 3 shared papers, 2018–2024 · strength 0.42
- Paper Endoscopic Ultrasound Can Differentiate High-Grade Pancreatic Intraepithelial Neoplasia, Small Pancreatic Ductal Adenoc… DOI 10.5009/gnl220521↗
- Paper Diagnostic Strategy of Early Stage Pancreatic Cancer via Clinical Predictor Assessment: Clinical Indicators, Risk Facto… DOI 10.3390/diagnostics12020377↗
- Paper Utility of Endoscopic Ultrasonography Screening for Small Pancreatic Cancer and Proposal for a New Scoring System for S… DOI 10.1097/mpa.0000000000000988↗
- Keisuke Kinoshita · 2 shared papers, 2023 · strength 0.33
- Teijiro Hirashita · 2 shared papers, 2021–2023 · strength 0.25
- Masafumi Inomata · 2 shared papers, 2021–2023 · strength 0.25
- Naoki Hijiya · 2 shared papers, 2021–2023 · strength 0.25
- Masatsugu Moriyama · 2 shared papers, 2021–2023 · strength 0.25
- Shusaku Kurogi · 2 shared papers, 2021–2023 · strength 0.25
- Jun Nakahodo · 1 shared paper, 2024 · strength 0.20
- Kentaro Yamao · 1 shared paper, 2024 · strength 0.20
- Kenji Yamao · 1 shared paper, 2024 · strength 0.20
- Kazuyoshi Yanagihara · 1 shared paper, 2023 · strength 0.14
- Kohei Amada · 1 shared paper, 2023 · strength 0.14
- Masayuki Kitano · 1 shared paper, 2018 · strength 0.09
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.